Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

SHA:600285 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	570.93	1,228	1,499	1,179	801.24	732.32
Short-Term Investments	-	-	95.63	125.34	140.77	40.08
Trading Asset Securities	-	-	0.21	150.42	280.19	57.23
Cash & Short-Term Investments	570.93	1,228	1,595	1,455	1,222	829.63
Cash Growth	-66.64%	-22.97%	9.60%	19.05%	47.32%	7.88%
Accounts Receivable	698.92	488.95	498.99	511.97	431.18	708.6
Other Receivables	19.89	6.23	19.35	21.37	9.58	8.54
Receivables	718.81	495.17	518.34	533.34	440.77	717.13
Inventory	384.42	434.97	467.35	486.41	428.39	331.41
Prepaid Expenses	-	-	-	-	-	0.38
Other Current Assets	330.25	299.51	18.51	33.58	39.87	37.98
Total Current Assets	2,004	2,458	2,599	2,508	2,131	1,917
Property, Plant & Equipment	707.13	631.2	647.81	706.76	732.92	730.03
Long-Term Investments	250.04	257.15	1,069	676.63	364.7	349.75
Goodwill	482.02	-	-	-	-	-
Other Intangible Assets	317.12	203.75	202.5	203.65	236.95	235.04
Long-Term Deferred Tax Assets	224.24	199.59	186.92	159.2	116.49	97.79
Long-Term Deferred Charges	52.03	12.34	36.73	51.54	65.53	87.15
Other Long-Term Assets	1,374	1,255	29.98	38.45	145.25	41.45
Total Assets	5,411	5,017	4,772	4,345	3,793	3,458
Accounts Payable	85.79	85.13	57.38	68.02	78.01	78.81
Accrued Expenses	159.76	154.19	1,110	917.79	600.38	528.26
Short-Term Debt	81.36	33.27	199.94	151.15	272.34	166
Current Portion of Long-Term Debt	2.43	1.78	-	-	-	-
Current Portion of Leases	-	-	1.08	1.22	1.65	-
Current Income Taxes Payable	112.06	77.79	70.72	55.54	46.9	52.46
Current Unearned Revenue	63.71	114.28	114.48	153.75	79.09	71.73
Other Current Liabilities	1,481	1,408	346.95	364.47	359.28	169.01
Total Current Liabilities	1,986	1,874	1,900	1,712	1,438	1,066
Long-Term Leases	5.21	6.55	6.96	6.2	7.9	-
Long-Term Unearned Revenue	35.36	33.4	39.78	38.55	42.78	48.26
Long-Term Deferred Tax Liabilities	40.36	22.27	26.32	29.56	18.18	21.09
Total Liabilities	2,067	1,937	1,973	1,786	1,507	1,136
Common Stock	567.12	567.12	567.14	567.46	567.76	567.81
Additional Paid-In Capital	347.27	340.61	326.23	309.82	272.02	319.63
Retained Earnings	2,407	2,181	1,894	1,664	1,481	1,340
Treasury Stock	-13.7	-13.7	-47.4	-67.62	-98.19	-
Comprehensive Income & Other	4.28	-2.02	51	76.74	56.08	84.87
Total Common Equity	3,312	3,073	2,791	2,551	2,279	2,313
Minority Interest	32.35	7.77	7.66	7.55	7.59	9.43
Shareholders' Equity	3,344	3,080	2,799	2,558	2,287	2,322
Total Liabilities & Equity	5,411	5,017	4,772	4,345	3,793	3,458
Total Debt	89	41.6	207.99	158.57	281.89	166
Net Cash (Debt)	481.93	1,187	1,387	1,296	940.31	663.63
Net Cash Growth	-71.23%	-14.42%	6.96%	37.88%	41.69%	35.98%
Net Cash Per Share	0.85	2.10	2.45	2.28	1.66	1.17
Filing Date Shares Outstanding	566.1	564.42	563.94	569.61	564.55	562.16
Total Common Shares Outstanding	566.1	564.42	563.94	569.61	564.55	567.81
Working Capital	18.3	583.7	698.77	796.44	693.59	850.28
Book Value Per Share	5.85	5.44	4.95	4.48	4.04	4.07
Tangible Book Value	2,512	2,869	2,589	2,347	2,042	2,078
Tangible Book Value Per Share	4.44	5.08	4.59	4.12	3.62	3.66
Buildings	-	-	593.96	595.01	582.83	577.6
Machinery	-	-	581.63	581.92	534.7	511.65
Construction In Progress	-	-	2.88	1.92	24.78	2.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.